Physician

Khaled M Rabadi, MD

According to 2025 Medicare claims, Khaled Rabadi, MD (NPI: 1639180425) practices nephrology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is KIDNEY AND HYPERTENSION PLC (NPI: 1285742262; TIN: 710880821) and primary practice location at 58201-3434. Rabadi is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rabadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 694 traditional Medicare patients, billed 14,919 HCPCS/CPT codes, and received $528,770 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,946 prescription claims across 521 beneficiaries totaling $873,964 in drug costs, led by Ozempic (Semaglutide). DME data shows 907 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $309,785 to $528,770. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and rose steadily, from $48,469 to $90,425.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	562	5,207	$309,785
2016	514	4,163	$254,025
2017	534	2,802	$283,308
2018	534	2,943	$303,365
2019	616	3,906	$364,184
2020	608	3,175	$319,501
2021	746	3,978	$342,226
2022	919	11,283	$483,499
2023	731	15,416	$506,015
2024	694	14,919	$528,770

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	407	7,759	$605,887
2016	406	8,567	$709,559
2017	421	8,860	$701,919
2018	416	8,981	$687,541
2019	460	8,072	$643,445
2020	477	8,005	$591,972
2021	481	7,636	$513,559
2022	620	8,245	$694,999
2023	563	9,986	$1,119,971
2024	521	9,946	$873,964

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	124	787	$47,994
2016	145	1,034	$61,666
2017	157	1,005	$41,794
2018	138	1,020	$47,980
2019	188	998	$48,287
2020	212	1,014	$43,437
2021	77	811	$40,388
2022	143	834	$44,431
2023	237	944	$69,845
2024	173	907	$93,412

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	377	939	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	331	769	$12
80053	Blood test, comprehensive group of blood chemicals	356	1,221	$10
36415	Insertion of needle into vein for collection of blood sample	386	1,357	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	333	1,071	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	124	4,298	$137,084
Eliquis	Apixaban	118	5,163	$92,258
Januvia	Sitagliptin Phosphate	72	3,166	$58,049
Novolog Flexpen	Insulin Aspart	80	3,063	$42,868
Xarelto	Rivaroxaban	27	1,590	$29,717

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	31	115	$62,202
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	81	$6,389
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	12	$6,134
J7500	Azathioprine, oral, 50 mg	N	N/R	12	$1,832
A7030	Full face mask used with positive airway pressure device, each	N	N/R	18	$1,702

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Khaled M. Rabadi, MD?

Tedicare shows public-source Medicare data for Khaled M. Rabadi, MD (NPI 1639180425), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khaled M. Rabadi, MD have ACO affiliation data?

Khaled M. Rabadi, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Khaled M. Rabadi, MD?

Khaled M. Rabadi, MD is linked to KIDNEY AND HYPERTENSION PLC (billing NPI 1285742262) in the available physician profile data.

Does Khaled M. Rabadi, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.